ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,184, issued on Sept. 15, was assigned to Vifor AG (St. Gallen, Switzerland).
"Clinical dosing schedule of inositol phosphate oligo(ethylene glycol) compounds" was invented by Mattias Emanuel Ivarsson (Zurich, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a dosing schedule for an inositol polyphosphate oligo(ethylene glycol) compound, or its pharmaceutically acceptable salt used in the treatment or prevention of a disease associated with formation of, and/or tissue exposure to, calcium salt crystals. The drug compound is administered at an interval of one week."
The patent was filed on Jan. 26, 2022, under Appl...